These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Ex vivo study of 5-HT(1A) and 5-HT(7) receptor agonists and antagonists on cAMP accumulation during memory formation and amnesia. Perez-García G; Meneses A Behav Brain Res; 2008 Dec; 195(1):139-46. PubMed ID: 18723050 [TBL] [Abstract][Full Text] [Related]
44. Low-dose pretreatment with clorgyline decreases the levels of 3-methoxy-4-hydroxyphenylglycol in the striatum and nucleus accumbens and attenuates methamphetamine-induced conditioned place preference in rats. Kitanaka N; Kitanaka J; Watabe K; Takemura M Neuroscience; 2010 Feb; 165(4):1370-6. PubMed ID: 19958817 [TBL] [Abstract][Full Text] [Related]
47. Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Lu P; Mamiya T; Lu L; Mouri A; Niwa M; Kim HC; Zou LB; Nagai T; Yamada K; Ikejima T; Nabeshima T Behav Brain Res; 2010 Mar; 207(2):387-93. PubMed ID: 19857526 [TBL] [Abstract][Full Text] [Related]
48. The effects of high-dose methamphetamine in the aging rat: differential reinforcement of low-rate 72-s schedule behavior and neurochemistry. Sabol KE; Richards JB; Yung K J Pharmacol Exp Ther; 2000 Sep; 294(3):850-63. PubMed ID: 10945833 [TBL] [Abstract][Full Text] [Related]
49. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity. Biezonski DK; Meyer JS J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520 [TBL] [Abstract][Full Text] [Related]
50. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Segal DS; Kuczenski R; O'Neil ML; Melega WP; Cho AK Neuropsychopharmacology; 2003 Oct; 28(10):1730-40. PubMed ID: 12865898 [TBL] [Abstract][Full Text] [Related]
51. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654 [TBL] [Abstract][Full Text] [Related]
52. Modifications of 5-HT4 receptor expression in rat brain during memory consolidation. Manuel-Apolinar L; Rocha L; Pascoe D; Castillo E; Castillo C; Meneses A Brain Res; 2005 Apr; 1042(1):73-81. PubMed ID: 15823255 [TBL] [Abstract][Full Text] [Related]
53. A sensitizing regimen of methamphetamine causes impairments in a novelty preference task of object recognition. Belcher AM; O'Dell SJ; Marshall JF Behav Brain Res; 2006 Jun; 170(1):167-72. PubMed ID: 16600393 [TBL] [Abstract][Full Text] [Related]
54. Effects of 5-HT drugs in prefrontal cortex during memory formation and the ketamine amnesia-model. Liy-Salmeron G; Meneses A Hippocampus; 2008; 18(9):965-74. PubMed ID: 18570192 [TBL] [Abstract][Full Text] [Related]